REGENXBIO, Inc. (RGNX)
9.35
-0.03
(-0.32%)
USD |
NASDAQ |
Aug 27, 10:28
REGENXBIO EPS Diluted (TTM) : -3.785 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.785 |
| March 31, 2026 | -5.59 |
| December 31, 2025 | -3.754 |
| September 30, 2025 | -3.490 |
| June 30, 2025 | -3.464 |
| March 31, 2025 | -3.135 |
| December 31, 2024 | -4.638 |
| September 30, 2024 | -5.034 |
| June 30, 2024 | -5.269 |
| March 31, 2024 | -5.877 |
| December 31, 2023 | -6.027 |
| September 30, 2023 | -5.982 |
| June 30, 2023 | -6.319 |
| March 31, 2023 | -6.246 |
| December 31, 2022 | -6.498 |
| September 30, 2022 | 1.556 |
| June 30, 2022 | 1.931 |
| March 31, 2022 | 2.157 |
| December 31, 2021 | 2.745 |
| September 30, 2021 | -5.161 |
| June 30, 2021 | -3.565 |
| March 31, 2021 | -3.115 |
| December 31, 2020 | -2.995 |
| September 30, 2020 | -2.476 |
| Date | Value |
|---|---|
| June 30, 2020 | -3.642 |
| March 31, 2020 | -2.775 |
| December 31, 2019 | -2.582 |
| September 30, 2019 | -1.755 |
| June 30, 2019 | -1.380 |
| March 31, 2019 | -1.041 |
| December 31, 2018 | 2.886 |
| September 30, 2018 | 2.265 |
| June 30, 2018 | 2.16 |
| March 31, 2018 | 1.39 |
| December 31, 2017 | -2.47 |
| September 30, 2017 | -2.701 |
| June 30, 2017 | -2.716 |
| March 31, 2017 | -2.794 |
| December 31, 2016 | -2.383 |
| September 30, 2016 | -1.842 |
| June 30, 2016 | -2.681 |
| March 31, 2016 | -2.479 |
| December 31, 2015 | -2.165 |
| September 30, 2015 | -1.957 |
| June 30, 2015 | -0.4325 |
| March 31, 2015 | -0.0869 |
| March 31, 2014 | 0.0081 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AbbVie, Inc. | 3.537 |
| Capricor Therapeutics, Inc. | -2.449 |
| Biogen, Inc. | 5.647 |
| Ardelyx, Inc. | -0.2261 |
| Ocugen, Inc. | -0.2547 |